[Treatment of @entity1459 . A randomized double-blind study of @entity1169 , XXXX and @entity17728 ].

@entity1 @entity1169 @entity39 @entity63 @entity3988 @entity1459 @entity951 @entity158 @entity204 @entity17728
A randomized, multicentric, double blind study attempted to compare in 41 @entity1 hospitalized for @entity1459 , the efficacy of @entity3988 (D) 240 mg/day, @entity1169 (P) 160 mg/day and @entity17728 (M) 8 mg/day. The @entity1 included in the study presented one or several spontaneous @entity951 episodes accompanied by a transient and significant lowering of ST and/or an inverted T wave without @entity39 . The evaluation criteria were the occurrence of new @entity158 and electrical alterations on a continuous Holter for 5 days. 11 @entity1 received @entity3988 , 13 @entity1 received @entity1169 and 15 @entity1 received @entity17728 (including an @entity204 ). Clinically, the number of @entity158 episodes per day and per @entity1 goes, in an average, from 1.2 to 0.23 @entity3988 , from 2.2 to 0.44 for @entity1169 and from 2.2 to 0.45 for @entity17728 . @entity158 disappeared on the 5th day in 54.5 per cent of @entity1 under @entity3988 , 58.8 per cent of @entity1 under @entity1169 and 53.5 per cent of @entity1 under @entity17728 . Electrically, the number of @entity63 accidents per day and per @entity1 was 0.45 under @entity3988 , 2.12 under @entity1169 (0.53 in excluding one @entity1 with @entity951 ) and 0.81 under @entity17728 . The number of @entity1 without any @entity63 accident was 63.6 per cent under @entity3988 , 53.8 per cent under @entity1169 and 40 per cent under @entity17728 . In conclusion, @entity3988 , @entity1169 , and @entity17728 have a comparable efficacy in @entity1459 . The association of these medications could have a synergistic effect.
